title: Comparison between dietary soybean protein and casein of the inhibiting effect on atherogenesis in the thoracic aorta of hypercholesterolemic (ExHC) rats treated with experimental hypervitamin D.
abstract: Atherosclerotic lesions of the thoracic aorta were induced in exogenously hypercholesterolemic (ExHC) rats by treating initially with hypervitamin D2 and subsequently feeding on hypercholesterolemic diets for 180 days. Dietary soybean protein, in comparison with casein, substantially decreased the degree of atherosclerotic lesions, which was evaluated by intimal thickening, although with a similar topographical distribution. The casein-fed rats tended to maintain a high concentration of serum cholesterol, particularly in triacylglycerol-rich lipoproteins. The concentrations of apo A-I and TBARS in the serum was comparable between the dietary protein groups. The data suggest that dietary soybean protein, compared to casein, produced lipoproteins which were less atherosclerotic by partitioning cholesterol in the triacylglycerol-poor lipoproteins.
authors.affiliation: Department of Food Science and Technology, Faculty of Agriculture, Kyushu University, Fukuoka, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Sakono
authors.forename: T
authors.initials: T
authors.lastname: Fukuyama
authors.forename: W H
authors.initials: WH
authors.lastname: Ni
authors.forename: K
authors.initials: K
authors.lastname: Nagao
authors.forename: H R
authors.initials: HR
authors.lastname: Ju
authors.forename: M
authors.initials: M
authors.lastname: Sato
authors.forename: N
authors.initials: N
authors.lastname: Sakata
authors.forename: H
authors.initials: H
authors.lastname: Iwamoto
authors.forename: K
authors.initials: K
authors.lastname: Imaizumi
mesh_terms: D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects* / Q000293:injuries / Q000473:pathology; D016632:Apolipoprotein A-I / Q000097:blood; D001161:Arteriosclerosis / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control*; D002364:Caseins / Q000008:administration & dosage / Q000494:pharmacology*; D002784:Cholesterol / Q000097:blood; D004195:Disease Models, Animal; D004872:Ergocalciferols / Q000008:administration & dosage / Q000633:toxicity; D006937:Hypercholesterolemia / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D051381:Rats; D030262:Soybean Proteins / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D013194:Staining and Labeling; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism; D014280:Triglycerides / Q000097:blood
chemical_list: D016632:Apolipoprotein A-I; D002364:Caseins; D004872:Ergocalciferols; D030262:Soybean Proteins; D017392:Thiobarbituric Acid Reactive Substances; D014280:Triglycerides; D002784:Cholesterol